EUVIMEDEUVIMED entdecken
Open Access

Clonal Hematopoiesis in Patients With Human Immunodeficiency Virus and Cancer

Nancy Gillis iD, Brittney L Dickey iD, Christelle Colin-Leitzinger iD, Yi-Han Tang, Ryan M Putney, Tania E Mesa, Sean J Yoder, Gita Suneja iD, Adam M Spivak iD, Ami B Patel, Martine Extermann iD, Anna R Giuliano iD und 4 weitere

The Journal of Infectious Diseases · 23.09.2024 · 230 (3) · 680-688

DOI: 10.1093/infdis/jiae212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 24.04.2024. Verfasst von Nancy Gillis und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Hauptthemen laut MEDLINE: HIV Infections, Clonal Hematopoiesis, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer-related deaths for people with human immunodeficiency virus (PWH) are increasing due to longer life expectancies and disparately poor cancer-related outcomes. We hypothesize that advanced biological aging contributes to cancer-related morbidity and mortality for PWH and cancer. We sought to determine the impact of clonal hematopoiesis (CH) on cancer disparities in PWH.

Methods

We conducted a retrospective study to compare the prevalence and clinical outcomes of CH in PWH and people without HIV (PWoH) and cancer. Included in the study were PWH and similar PWoH based on tumor site, age, tumor sequence, and cancer treatment status. Biological aging was also measured using epigenetic methylation clocks.

Results

In 136 patients with cancer, PWH had twice the prevalence of CH compared to similar PWoH (23% vs 11%, P = .07). After adjusting for patient characteristics, PWH were 4 times more likely than PWoH to have CH (odds ratio, 4.1 [95% confidence interval, 1.3–13.9]; P = .02). The effect of CH on survival was most pronounced in PWH, who had a 5-year survival rate of 38% if they had CH (vs 59% if no CH), compared to PWoH who had a 5-year survival rate of 75% if they had CH (vs 83% if no CH).

Conclusions

This study provides the first evidence that PWH may have a higher prevalence of CH than PWoH with the same cancers. CH may be an independent biological aging risk factor contributing to inferior survival for PWH and cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsClonal HematopoiesisNeoplasmsHumansMaleFemaleMiddle AgedRetrospective StudiesAdultPrevalenceAged

Stichwörter der Autor:innen

HIVbiological agecancerclonal hematopoiesisrisk factors

Autor:innen und Institutionen

  • Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Molecular Genomics Core Facility, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

ORCID-Profile: Nancy Gillis, Brittney L Dickey, Christelle Colin-Leitzinger, Gita Suneja, Adam M Spivak, Martine Extermann, Anna R Giuliano, Mingxiang Teng, Jacob Kresovich, Anna E Coghill

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Gillis, N., Dickey, B. L., Colin-Leitzinger, C., Tang, Y. H., Putney, R. M., Mesa, T. E., Yoder, S. J., Suneja, G., Spivak, A. M., Patel, A. B., Extermann, M., Giuliano, A. R., Teng, M., Kresovich, J., Berglund, A., & Coghill, A. E. (2024). Clonal Hematopoiesis in Patients With Human Immunodeficiency Virus and Cancer. The Journal of Infectious Diseases, 230(3), 680-688. https://doi.org/10.1093/infdis/jiae212

Vancouver

Gillis N, Dickey BL, Colin-Leitzinger C, Tang YH, Putney RM, Mesa TE, et al. Clonal Hematopoiesis in Patients With Human Immunodeficiency Virus and Cancer. The Journal of Infectious Diseases. 2024;230(3):680-688. doi:10.1093/infdis/jiae212

BibTeX
@article{Gillis2024,
  author = {Gillis, Nancy and Dickey, Brittney L and Colin-Leitzinger, Christelle and Tang, Yi-Han and Putney, Ryan M and Mesa, Tania E and Yoder, Sean J and Suneja, Gita and Spivak, Adam M and Patel, Ami B and Extermann, Martine and Giuliano, Anna R and Teng, Mingxiang and Kresovich, Jacob and Berglund, Anders and Coghill, Anna E},
  title = {Clonal Hematopoiesis in Patients With Human Immunodeficiency Virus and Cancer},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  volume = {230},
  number = {3},
  pages = {680--688},
  doi = {10.1093/infdis/jiae212}
}
Kostenlos starten →